Smoking risk in cardiovascular and cerebrovascular diseases

Andreia Filipa Fonseca Carriço (Guarda, Portugal), Andreia Filipa Fonseca Carriço, Filipa Fernandes, Rita Gomes, Filomena Luís

Source: International Congress 2016 – Smoking-related diseases
Session: Smoking-related diseases
Session type: Thematic Poster
Number: 4326
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andreia Filipa Fonseca Carriço (Guarda, Portugal), Andreia Filipa Fonseca Carriço, Filipa Fernandes, Rita Gomes, Filomena Luís. Smoking risk in cardiovascular and cerebrovascular diseases. Eur Respir J 2016; 48: Suppl. 60, 4326

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Contribution of respiratory disease and smoking to in-hospital mortality
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Quitting smoking and reduction of cardiovascular risk factors
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Tabagism, Physical activity and cardiovascular risk in youth. An analysis of MACISTE study
Source: International Congress 2016 – Clinical exercise physiology in health and disease
Year: 2016


Cigarette smoking has protective effect on blood pressure and obesity
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013


The importance of smoking as a risk factor of hypertension development in the Arctic region
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020


Smoking habits in high cardiovascular risk patients
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020


Prevalence of COPD in vascular diseases
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Cardiovascular diseases and COVID-19
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


Smoking cessation in CV diseases
Source: ERS Course 2015
Year: 2015




Smoking and lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 169s
Year: 2007

Association between cigarette smoking and suicide in psychiatric inpatients
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013


Smoking as a risk factor for survival in heart transplantation
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


COPD exacerbations occur more frequently in the presence of cardiovascular and pulmonary comorbidities and increase serum lipids
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Tobacco smoking and cardiovascular parameters
Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Year: 2011

Evaluation of smoking cessation among patients with respiratory or cardiac disease after 6 months of hospitalization
Source: International Congress 2014 – Twenty views of smoking cessation and physical activity
Year: 2014

Determinants and assessment of excess cardiovascular risk in bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015